I think that with the team that they have dedicated to just this project alone, they maybe closer than we think.
I believe with this milestone they only would have fabricated what was necessary to validate the biochip design. Now that they know it works, they can confidently go all out to build a more comprehensive package for commercial validation.
In regard to any confusion (if it exists) around what is hardware or software related tweaks, what benefit does it serve us shareholders to know everything at this point in time?
AXE remains a black box. We just have to accept that we don’t know what’s inside – yet! Nevertheless, I’m more excited than ever with every milestone that is reached.
Exciting times – we shall see soon enough!
AIMO, DYOR, GLTA(Patient)H
AXE Price at posting:
50.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)